2 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow telavancin: new trials by email Literature Review of telavancin trials Research Report on telavancin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Telavancin in Normal and Obese Subjects Telavancin - Healthy | Phase 1 | Completed | University of Illinois at Chicago | 32 | 2016-04-01 | 2016-11-02 |
| Telavancin Pediatric PK Study (Ages >12 Months to 17 Years) Telavancin - Gram-Positive Bacterial Infections | Phase 1 | Terminated | Cumberland Pharmaceuticals | 22 | 2014-12-01 | 2024-06-24 |
| A Study to Evaluate the Effect of Renal Function on the Biological Activity of Telavancin telavancin - Kidney Diseases, End Stage Renal Disease | Phase 1 | Completed | Cumberland Pharmaceuticals | 45 | 2010-12-01 | 2019-01-15 |
Gram-Positive Bacterial Infections (1) · Kidney Diseases (1) · Kidney Failure, Chronic (1)
Cumberland Pharmaceuticals (2) · University of Illinois at Chicago (1)
United States (3)
Keith A. Rodvold, Pharm.D. (1)